Table 3.
Region-wise probability of incidence and death due to colorectal cancer
| Incidence | Deaths | |||||
|---|---|---|---|---|---|---|
| Population | Both | Male | Female | Both | Male | Female |
| Australia and New Zealand | 7.83 (1 in 13) | 8.98 (1 in 11) | 6.75 (1 in 15) | 2.77 (1 in 36) | 3.16 (1 in 32) | 2.4 (1 in 42) |
| Caribbean | 3.97 (1 in 25) | 4.01 (1 in 25) | 3.94 (1 in 25) | 2.37 (1 in 42) | 2.45 (1 in 41) | 2.29 (1 in 44) |
| Central America | 2.17 (1 in 46) | 2.38 (1 in 42) | 1.98 (1 in 51) | 1.17 (1 in 85) | 1.3 (1 in 77) | 1.06 (1 in 94) |
| Central and Eastern Europe | 5.9 (1 in 17) | 7.92 (1 in 13) | 4.7 (1 in 21) | 3.56 (1 in 28) | 4.93 (1 in 20) | 2.78 (1 in 36) |
| Eastern Africa | 1.49 (1 in 67) | 1.54 (1 in 65) | 1.45 (1 in 69) | 1.19 (1 in 84) | 1.28 (1 in 78) | 1.12 (1 in 89) |
| Eastern Asia | 5.67 (1 in 18) | 6.86 (1 in 15) | 4.58 (1 in 22) | 2.83 (1 in 35) | 3.44 (1 in 29) | 2.28 (1 in 44) |
| Melanesia | 2.82 (1 in 35) | 4.23 (1 in 24) | 1.75 (1 in 57) | 1.85 (1 in 54) | 3.02 (1 in 33) | 0.97 (1 in 103) |
| Micronesia | 3.63 (1 in 28) | 4.1 (1 in 24) | 3.13 (1 in 32) | 1.81 (1 in 55) | 2.69 (1 in 37) | 1.09 (1 in 92) |
| Middle Africa | 1.72 (1 in 58) | 1.84 (1 in 54) | 1.63 (1 in 61) | 1.47 (1 in 68) | 1.61 (1 in 62) | 1.37 (1 in 73) |
| North America | 5.18 (1 in 19) | 5.88 (1 in 17) | 4.57 (1 in 22) | 1.88 (1 in 53) | 2.21 (1 in 45) | 1.59 (1 in 63) |
| Northern Africa | 1.68 (1 in 60) | 1.9 (1 in 53) | 1.51 (1 in 66) | 1.14 (1 in 88) | 1.35 (1 in 74) | 0.97 (1 in 103) |
| Northern Europe | 6.89 (1 in 15) | 8.23 (1 in 12) | 5.74 (1 in 17) | 2.9 (1 in 34) | 3.55 (1 in 28) | 2.37 (1 in 42) |
| Polynesia | 3.48 (1 in 29) | 4.53 (1 in 22) | 2.55 (1 in 39) | 0.77 (1 in 130) | 1.35 (1 in 74) | 0.26 (1 in 385) |
| South America | 3.91 (1 in 26) | 4.42 (1 in 23) | 3.51 (1 in 28) | 2.14 (1 in 47) | 2.53 (1 in 40) | 1.84 (1 in 54) |
| South-Central Asia | 0.93 (1 in 108) | 1.2 (1 in 83) | 0.68 (1 in 147) | 0.72 (1 in 139) | 0.95 (1 in 105) | 0.5 (1 in 200) |
| South-Eastern Asia | 2.92 (1 in 34) | 3.65 (1 in 27) | 2.35 (1 in 43) | 1.84 (1 in 54) | 2.36 (1 in 42) | 1.46 (1 in 68) |
| Southern Africa | 2.89 (1 in 35) | 3.78 (1 in 26) | 2.37 (1 in 42) | 1.72 (1 in 58) | 2.37 (1 in 42) | 1.35 (1 in 74) |
| Southern Europe | 6.64 (1 in 15) | 8.66 (1 in 12) | 4.95 (1 in 20) | 2.89 (1 in 35) | 3.92 (1 in 26) | 2.06 (1 in 49) |
| Western Africa | 1.15 (1 in 87) | 1.24 (1 in 81) | 1.07 (1 in 93) | 0.9 (1 in 111) | 0.99 (1 in 101) | 0.82 (1 in 122) |
| Western Asia | 3.38 (1 in 30) | 4.15 (1 in 24) | 2.75 (1 in 36) | 2.05 (1 in 49) | 2.5 (1 in 40) | 1.69 (1 in 59) |
| Western Europe | 6.12 (1 in 16) | 7.48 (1 in 13) | 4.94 (1 in 20) | 2.6 (1 in 38) | 3.32 (1 in 30) | 1.99 (1 in 50) |
Data source: cumulative risk of developing and dying from cancer (before age 85) were procured from GLOBOCAN 2018 and the odds were calculated using the CRC risk. Odds of developing and dying from CRC are presented inside parenthesis